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Abstract
Traditionally, the concept of allergy implied an abnormal response to an otherwise benign agent 
(eg, pollen or food), with an easily identifiable relationship between exposure and disease. 
However, there are syndromes in which the relationship between exposure to the relevant allergen 
and the “allergic” disease is not clear. In these cases the presence of specific IgE antibodies can 
play an important role in identifying the relevant allergen and provide a guide to therapy. Good 
examples include chronic asthma and exposure to perennial indoor allergens and asthma related to 
fungal infection. Finally, we are increasingly aware of forms of food allergy in which the 
relationship between exposure and the disease is delayed by 3 to 6 hours or longer. Three forms of 
food allergy with distinct clinical features are now well recognized. These are (1) anaphylactic 
sensitivity to peanut, (2) eosinophilic esophagitis related to cow’s milk, and (3) delayed 
anaphylaxis to red meat. In these syndromes the immunology of the response is dramatically 
different. Peanut and galactose α-1,3-galactose (alpha-gal) are characterized by high- or very high-
titer IgE antibodies for Ara h 2 and alpha-gal, respectively. By contrast, eosinophilic esophagitis is 
characterized by low levels of IgE specific for milk proteins with high- or very high-titer IgG4 to 
the same proteins. The recent finding is that patients with alpha-gal syndrome do not have 
detectable IgG4 to the oligosaccharide. Thus the serum results not only identify relevant antigens 
but also provide a guide to the nature of the immune response.
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The first awareness of immediate hypersensitivity came from the separate investigations of 
seasonal hay fever over the period 1870–1910 by Blackley, Wymann, Noon, and Von 
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Pirquet.1 At that point, no evidence of an immune response to pollen could be detected in 
serum from these patients.2 However, in 1921, Prausnitz and Kustner showed that serum of 
allergic subjects could transfer sensitivity locally in the skin.3 This Prausnitz-Kustner test 
was used widely between 1921 and 1960 and played a major role in the discovery of IgE. 
Once IgE was established, it was possible to investigate many different aspects of allergic 
disease both in terms of diagnosis and in understanding the relevant treatment. Thus the 
discovery of IgE completely changed the investigation of these diseases because 
measurements were of a specific molecule measured in fully defined units (first in 
international units and then by absolute quantitation; ie, 2.4 ng/unit). The initial purification 
of Prausnitz-Kustner activity was primarily related to ragweed pollen.4 Interestingly, 
Ishizaka et al4 did not consider that the establishment of a new isotype of immunoglobulin, 
IgE, changed the argument about the causal role of pollen in hay fever. By contrast, 
measurement of IgE has now played a major role in the diagnosis of many allergic diseases 
other than hay fever. However, it has to be admitted that it is difficult to replicate the simple 
elegance of the evidence about the role of airborne pollen grains in hay fever.
Early in the 20th century, Coca5 became Editor of the Journal of Immunology and proposed 
the concept of atopy or the hereditary tendency to become allergic to allergens in the 
environment. He included asthma, food allergy, and eczema, as well as hay fever, among the 
atopic diseases. Furthermore, he clearly implied that the sensitizing allergens had a causal 
role in these diseases. For the main forms of food allergy recognized at that time (eg, fish, 
nuts, egg, or milk), the rapid development of symptoms, including hives or angioedema, 
after exposure left little doubt about causality. By contrast, for chronic asthma in patients 
sensitized to 1 or more of the perennial allergens, the evidence of a relationship between 
allergens and disease is more difficult to establish. This is particularly true for allergens, 
such as dust mite or cockroach, where the allergens only become airborne during 
disturbance.6,7 We would like to focus on the evidence for causality and the role of IgE in 
relation to 3 conditions:
1. chronic asthma in patients who are sensitized to 1 or more perennial allergens;
2. allergic symptoms in patients who are colonized with fungi in their lungs, 
sinuses, or nails; and
3. the different forms of food allergy, including those newly recognized syndromes 
in which the relationship between exposure and response is not “immediate.”
CHRONIC ASTHMA IN PATIENTS WITH SENSITIZATION TO 1 OR MORE 
PERENNIAL ALLERGENS
The opinion about the relevance of perennial allergen exposure to chronic asthma has 
differed from enthusiastic acceptance to denial or, worst of all, complete indifference.8,9 In 
part, this reflects the failure of some important avoidance studies and the relentless pressure 
for treatment with pharmaceutical products. A more important cause is that the relationship 
between exposure and symptoms is not simple. Indeed, for mite, cockroach, “domestic” 
mice, and Alternaria species, patients often have very little sense that they are allergic and 
do not understand the role these allergens play in their asthma.10 For cat and dog, it is not 
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unusual for the allergic patients to report that they have acute symptoms on entering a house 
with a relevant animal. However, in many communities the majority of patients with cat 
allergy do not live in a house with a cat, and nonetheless, sensitization is strongly associated 
with asthma.11,12 In some studies there is clear evidence that children raised in a house with 
a cat are less likely to be sensitized.12 However, for cat, the levels of this allergen in schools 
and homes without a cat increases with the prevalence of domestic cats in the community.13 
Statements of this kind are possible because the source of these allergens can be identified 
(ie, 4-legged animals) and because of the availability of sensitive assays for relevant 
allergens in dust or airborne allergens.14 For cockroaches and mice, visual identification is 
possible but less reliable than measurement of specific allergens. For dust mites, there is no 
way of evaluating their presence or concentration in a house without microscopy or the use 
of an immunoassay.6,15
There are several major variables that have been used to understand the relationship of 
allergen exposure to IgE antibodies and asthma:
1. Many studies have been carried out in areas where dust mites flourish in all 
homes (eg, the United Kingdom, New Zealand, Australia, Costa Rica, and the 
Southeast or Northwest of the United States).16–19
2. Studies have been conducted in areas where, because of cold temperatures and 
low humidity, dust mites, cockroaches, and Alternaria species are either absent or 
at very low levels in homes.12,20,21
3. There are groups within the United States with dramatically different attitudes to 
animals, such that a large section of the population have much lower exposure 
and sensitization.19,22
4. Pollens and fungal spores, such as Alternaria species, have major seasonal and 
geographic differences in their outdoor particle counts. Since the 1950s, overall 
exposure to pollen allergens, particularly ragweed, has decreased considerably 
because of widespread use of home air conditioning, which started during the 
1960s.
DIAGNOSTIC RELEVANCE OF IgE ANTIBODIES TO ASTHMA
In almost all clinical studies, IgE antibodies or skin tests are carried out with extracts derived 
from the relevant allergens, and these include multiple proteins. The relevance of the results 
can be assessed based on the prevalence of positive test results, the titer of IgE antibody, or 
the size of wheals or, alternatively, by tests using specific proteins.13,23 Tests for 
sensitization to proteins can use purified or recombinant allergens, but these tests are carried 
out almost exclusively with in vitro assays.
There are many situations in which the significance of sensitization to certain specific 
proteins is different from that for the whole extract. A simple example is the tropomyosin 
Der p 10, which cross-reacts with both cockroach and shrimp and might not be a relevant 
inhalant allergen.23 A more complex situation has developed with cat extracts. The major 
inhalant allergen was purified by Ohman et al24 in 1974 as Cat 1, which subsequently 
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became Fel d 1. More recently, Fel d 4 has been recognized as a second major inhalant 
allergen.25 However, cat extracts can produce positive skin test or IgE assay results because 
of IgE to 2 allergens that are not relevant to inhalant allergy. The first of these is Fel d 2 (or 
cat albumin), which cross-reacts with pork albumin, giving rise to the pork-cat 
syndrome.26,27 The second is galactose α-1,3-galactose (alpha-gal), which has emerged as a 
major allergen related to red meat and is the main epitope on cat IgA.28–30 A major cause of 
confusion comes from the difference between pelt extracts, which contain cat albumin and 
many proteins carrying alpha-gal, and dander extracts, which may only contain significant 
quantities of Fel d 1.
UNDERSTANDING THE ROLE OF ALLERGENS IN ASTHMATIC PATIENTS 
AND THE RELEVANCE OF IgE ANTIBODIES
We would like to focus on 3 observations about chronic allergic asthma: (1) the strongest 
association is with sensitization to common perennial inhalant allergens, which is true in 
particular for high-titer IgE antibodies to allergens that are prevalent in the patient’s 
community; (2) the relevant allergens, such as dust mite, cat, dog, or cockroach, have been 
shown to become airborne on particles of 5 to 35 μm in diameter (Fig 1 and Table I); and (3) 
many or most acute episodes of wheezing cannot be related to increased or even high-level 
exposure to allergens. The implication of this last observation is that exacerbations are most 
likely occurring as a result of viral or other triggers in the context of underlying 
inflammation of the lungs and the associated bronchial hyperreactivity.18,31,32
In a simplistic view the fact that bronchial provocation of an allergic patient with nebulized 
allergen extract can induce both a decrease in FEV1 and eosinophil-rich inflammation of the 
lungs could be taken as evidence that allergen exposure is causally related to asthma. 
However, the contrast between natural exposure of the lungs to particles, such as mite feces, 
and a bronchial challenge with nebulized allergen could hardly be more extreme (Fig 2).33,34 
Exposure to dust mite allergen is thought to consist of 5 to 100 fecal particles entering the 
lungs per day. Nebulized allergen is estimated to be 10 million droplets inhaled over 2 to 5 
minutes, where each droplet is approximately 2 μm in diameter. Mite feces have been 
estimated to contain 0.2 ng of Der p 1, whereas the comparable figure for nebulized droplets 
is less than 10−7 ng (Table I).
We assume that deposition of a particle on the bronchial wall represents sufficient local 
allergen not only to activate mast cells but also to recruit eosinophils, basophils, and 
lymphocytes. What is not clear is how long such an inflammatory focus would last. Our 
view is that some consequences of local inflammation could persist for months or longer. 
These include persistence of changes in the vasculature that encourage local arrival of cells 
and persistence of allergen-specific T cells. It seems likely that allergen-specific T cells, as 
well as mast cells, could contribute to the long-term persistence of bronchial hyperreactivity. 
Taken together, the results could explain how IgE antibodies are relevant to the process and 
that locally accumulating T cells could be a target for peptide immunotherapy.35
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SENSITIZATION TO FUNGI COLONIZING THE SKIN, NAILS, OR LUNGS AS 
A RISK FACTOR FOR ALLERGIC DISEASE
There are literally hundreds of pollinating plants or fungi that produce spores, which can act 
as a source of inhalant allergens. By contrast, there are only a limited number of fungi that 
induce the production of specific IgE by growing on patients. Fungi can be found growing 
on the skin, on mucosal surfaces, in the sinuses, or in the lungs. In many cases these fungi 
have specific properties that facilitate their growth. Thus dermatophytes have a specific 
ability to grow on keratinized surfaces (ie, skin and nails). By contrast, Aspergillus species 
are able to grow both at the temperature of the soil and also at 37°C in the lungs or sinuses. 
Although the significance of fungal sensitization was recognized in the 1930s, acceptance of 
their clinical importance fluctuated until allergic bronchopulmonary aspergillosis (ABPA) 
was established by Hinson; Pepys; and Patterson.36,37 With the discovery of IgE, it became 
possible to define the diseases better and to show that many of these patients had IgE 
antibodies specific for fungal allergens. Although the primary focus of studies on fungal 
sensitization related to the lungs, it was recognized years ago that sensitization to both 
dermatophytes and Candida species can also be a cause of urticaria and angioedema.38 
Diagnostic criteria have been suggested for some fungal diseases; however, even with 
ABPA, a large proportion of patients who are growing either Aspergillus species or other 
fungi in their lungs do not fulfill the criteria for ABPA or allergic bronchopulmonary 
mycosis. These patients can be described as having forme fruste allergic broncho-pulmonary 
mycosis.
There is an important distinction between patients in whom the fungus is growing at the site 
of the inflammatory reaction, such as Aspergillus species or other fungi growing in the lungs 
or sinuses, and patients in whom fungi growing on the feet appear to be the cause of an 
inflammatory response elsewhere in the body.39–41 The latter form can be described as an 
“ID” reaction (ie, comparable with those skin lesions associated with pulmonary 
tuberculosis but did not contain organisms that could infect a guinea pig). Historically, 
Candida and Trichophyton species were well recognized by dermatologists as causes of ID 
reactions in the hands or skin.38,42 In Box 1 we present 3 cases that illustrate these 
differences.
Box 1
Three cases with severe allergic disease, documented fungal infection, 
sensitization, and response to antifungal treatment
• Case I: 43-year-old woman; repeated severe attacks of asthma; Candida 
species colonization of sinuses and lungs and full response to fluconazole; 
IgE to Candida albicans was 13.3 IU/mL.
• Case II: 62-year-old man; judge with almost continuous facial angioedema, 
taking 50 mg of prednisone per day; severe fungal infection of feet for “many 
years”; skin test Trichophyton ++ IgE antibody of 5.0 IU/mL; Trichophyton 
species grown from nail scrapings; no response to 3 months of fluconazole; 
full response to itraconazole over 1 year.
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• Case III: 56-year-old man; diving instructor; increasingly severe late-onset 
asthma; continuous obstruction with FEV1 of 45% of predicted value despite 
40 mg of prednisone per day; culture of bronchoalveolar lavage fluid grew 
Aspergillus and Nocardia species; successful treatment with voriconazole and 
Augmentin for 1 year
Over the last 30 years, the field of fungal sensitivity has changed progressively because of 
the availability and widespread use of new oral antifungal drugs. In the early 1980s, the only 
oral drugs that were available were griseofulvin and ketoconazole; both of these drugs had 
severe side effects. The first new drug to arrive was fluconazole, and then came itraconazole, 
terbinafine, and voriconazole.43–45 This means that there are not only better drugs that can 
be used to treat fungal infections associated with allergic disease but also there might be 
fewer cases of severe ony-chomycosis because of successful treatment in primary care. On 
the other hand, the use of antibiotics and steroids encourages growth of fungi, particularly 
yeasts. It is well recognized that many women need to take 2 or 3 doses of fluconazole when 
they are treated with antibiotics. It is a different question whether high-dose inhaled steroids 
can enhance yeast growth in the lungs. Our view is that all patients with severe asthma who 
produce sputum should be monitored for growth of aspergillus, yeasts, or other fungi in the 
lungs (see case I in Box 1).46
With all these fungal diseases, it is an open question whether it is necessary to obtain 
cultures before treatment. There is good evidence that patients with ABPA who are 
colonized with an Aspergillus species sensitive to itraconazole respond better to treatment 
with that drug.44 The in vitro tests of sensitivity of cultured fungi to antifungals are 
improving and have become more readily available. We would argue that identifying the 
species improves the understanding of the condition and can contribute to the success of 
treatment. On the other hand, Denning et al45 demonstrated that itraconazole could improve 
the outcome for patients with asthma who have skin sensitization to fungi without 
establishing the presence of a colonizing organism.46
ROLE OF IgE ASSAYS IN THE DIAGNOSIS OF DIFFERENT FORMS OF 
FOOD ALLERGY: PEANUT ANAPHYLAXIS, EOSINOPHILIC ESOPHAGITIS 
(EoE), AND DELAYED ANAPHYLAXIS TO RED MEAT (THE ALPHA-GAL 
SYNDROME)
Over the last 20 years, both the scientific investigation of allergic disease and the practice of 
allergy have moved progressively toward food allergy. In our practice in central Virginia, 
this has included major increases in 3 different forms of allergic reactions to food. The thing 
that is truly interesting about this is that these 3 forms of “allergy” appear to be distinct both 
in their clinical presentation and in their underlying immune response (Table II).28,29,47,48 
Peanut allergy is taken as the model for immediate and often anaphylactic reactions to food 
in children. This condition has been well recognized for many years but has increased 
rapidly during the period 1990–2010.49 Initially, it was possible to argue that there was 
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increased awareness of the disease, but the prevalence of high-titer IgE antibody in random 
cohorts of children has increased.50
The second form of food allergy is EoE, which was hardly recognized at all before 1990 and 
has become progressively more common over the last 20 years so that today most academic 
centers in the United States have an EoE clinic. The disease is characterized by chronic 
inflammation of the esophagus, which gets better with a diet including avoidance of cow’s 
milk.51–53 Although many of the children have detectable IgE antibodies to cow’s milk, 
wheat, egg, or soy proteins, the titers are consistently low (Fig 3).47 Recent studies have 
shown that almost all children with EoE have high- or very high-titer IgG4 antibodies to 
cow’s milk proteins.54,55 Clinically, patients with EoE continue eating cow’s milk proteins 
because they are not aware of being allergic. Thus EoE does not have the features of an IgE-
mediated disease and also does not improve during treatment with omalizumab. If EoE is a 
T cell–mediated disease, we should be able to focus on T cells that can recruit eosinophils, 
give rise to low levels of IgE, and strongly enhance IgG4. In addition, these findings have 
major implications for the correct treatment.
The third group of patients present with anaphylaxis or urticaria to red meat, which is most 
common in adults.29,56,57 Indeed, the typical case is a man older than 50 years with episodes 
of hives, angioedema, or anaphylaxis that start several hours after a meal including red meat. 
On skin testing, they have negative or weakly positive skin prick test responses to a 
commercial beef extract but strongly positive IgE assay results for the oligosaccha-ride 
alpha-gal.28,29,57,58 Similar syndromes have now been described in many countries, 
including Australia, Sweden, France, Germany, and Japan.57,59–61 In each of these countries, 
the reported reactions to meat have been delayed for several hours after eating, IgE antibody 
is directed at the same oligosaccharide, and there is reasonable or good evidence that tick 
bites are the primary cause of the sensitization.59,61,62 In our practice the presence of alpha-
gal–specific IgE that represents more than 1% of total IgE, a convincing report of bites from 
ticks (or chiggers), and a history of urticaria or anaphylaxis starting 2 to 6 hours after 
consuming red meat provide a high level of diagnostic certainty.
Evidence about these 3 forms of food allergy has provided a stronger basis for evaluating 
reactions to food in general, and several other syndromes have become much clearer. A 
simple example is the pork-cat syndrome, which was first recognized in Europe.26,27 In 
evaluating cases of reactions attributed to red meat, we found patients with negative results 
to alpha-gal but positive results to pork, and weak results to beef. In these cases the pork 
response was explained by IgE specific for pork albumin. Absorption studies provided 
evidence that cat albumin was responsible for the initial sensitization and that food reactions 
were due to cross-reactivity.27 Patients with IgE to alpha-gal can have delayed reactions to 
foods containing gelatin, such as marshmallows or jelly babies.63 This occurs because 
gelatin made from mammals can carry alpha-gal; however, in addition, there are patients 
who are allergic to the protein epitopes on gelatin. The gelatins cross-react extensively, and 
this has given rise to anaphylactic reactions to vaccines containing gelatin.64 Most recently, 
we have seen a case reporting delayed reactions to mammalian products, including cow’s 
milk and beef, who was negative to alpha-gal. In this case the dominant assay result was to 
milk, and the specific protein was BSA.65 What matters here is that testing IgE to specific 
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proteins and/or to the oligosaccharide alpha-gal makes it possible to identify the relevant 
allergens in many cases.
RELEVANCE OF THE ROUTE OF SENSITIZATION TO THE SPECIFICITY 
AND TITER OF IgE ANTIBODY RESPONSES
For many years, there have been questions about whether sensitization to allergens could 
occur through routes other than the inhaled or oral routes. The obvious example was atopic 
dermatitis, in which the skin is already damaged and IgE antibodies to inhalant allergens can 
reach high levels.66,67 Furthermore, patients with severe atopic dermatitis often have IgE 
specific for foods, bacterial antigens, and also fungi, particularly yeasts, such as 
Pityrosporum ovale.68,69 During the last 15 years, the evidence for sensitization through the 
skin has become much clearer. In relation to peanut allergy, it is well established that 
sensitization correlates with eczema and that use of topical treatments that incorporate 
peanut proteins increases the risk of sensitization. The success of early introduction of oral 
peanut in decreasing sensitization has added further evidence.48,70 Perhaps equally striking 
is the outbreak of wheat sensitization among women in Japan who use a mildly abrasive face 
preparation that contains wheat proteins.71–73
Given that the oral route can be tolerogenic and that there are obvious advantages to not 
becoming allergic to food, the question arises whether the skin route can break tolerance 
induced through the oral route. This question became more complicated with the discovery 
that sensitization to alpha-gal was common in large areas of the United States.28,56 It is now 
clear that tick bites are the dominant cause of this novel form of allergy in the United States 
and that this syndrome provides another example of high-titer IgE production in which the 
skin is the route of sensitization.59,62
Because we all make IgM and IgG2 specific to alpha-gal as part of an innate response to gut 
bacteria, it could be argued that the IgE response to alpha-gal must have broken tolerance. 
However, we have remarkably little understanding of either the immunology of IgE 
responses to oligosaccharides or the relevance of T cells in the response to tick bites. Initial 
studies in collaboration with Dr Rispens in Amsterdam suggested that the response to alpha-
gal does not include IgG4.74 Recently, we have extended those observations to confirm that 
neither the natural responses to this oligosaccharide nor the IgE-dominated response include 
IgG4.55 There is excellent evidence that oral desensitization of children with immediate 
hypersensitivity to milk or peanut can increase or induce IgG4 antibodies.48,70,75,76 Our 
current view is that the skin is an excellent route for inducing IgE to, for example, 
schistosomes, ticks, and peanut but in general is a poor route for inducing or boosting IgG4 
antibodies. The exception might be multiple bee stings. The early data on IgG4 argued that 
this response required prolonged exposure. We would add that the oral route might be the 
best route for boosting high levels of IgG4 in an already sensitized subject and that the 
esophagus might be an important route for this response (Fig 4).
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CONCLUSIONS
The 3 areas on which we have focused here were chosen because they illustrate the difficulty 
of understanding the role of allergens in diseases in which the relationship between exposure 
and the disease is not obvious to the patient. In these studies the ability to measure IgE levels 
to allergen extracts, purified proteins, and novel allergens has been central to understanding 
the nature of the condition. Our first experience with this process came from investigating 
the epidemic of asthma in children in the United Kingdom at a time when it was already 
clear that many of these children were allergic to dust mites. The proof that Der p 1 was a 
major target for IgE was an essential part of the definition of this protein as a major mite 
allergen.77 In turn, this was essential to proposing assays of Der p 1 in dust as a surrogate for 
microscopic counting of dust mites.6,15
Although sensitization to yeasts and dermatophytes was well known before the discovery of 
IgE, the level of scientific or clinical acceptance was “meager.” Purification of Aspergillus 
species allergens allowed measurements of IgG and IgE antibodies. Sensitization to 
Trichophyton species provides another example of the overall problem because very few of 
the patients have considered the possible relevance of the fungal infection on their feet to 
their disease. Purification of the relevant proteins was an important part of understanding the 
immune response that starts in the skin.41 Clinically, the availability of the newer anti-
fungals has completely changed the equation. We would stress that these cases continue to 
appear and that without considering fungal sensitization and using oral antifungal treatment, 
they will continue to be treated with high doses of steroids.
The 2 new syndromes of food allergy illustrate well the problems with diagnosis and 
treatment of allergic diseases in which allergen exposure does not give rise to immediate 
symptoms.
With EoE, the clearest guide to the relevance of foods comes from the response to diet and 
particularly from the exacerbations that can occur after reintroduction of specific foods. 
However, the esophageal symptoms do not reappear for 24 hours or more. Skin tests are 
generally not convincing in defining the important sensitivity. By using serum IgE assays, 
the presence of IgE to cow’s milk proteins is clear.53 Nonetheless, it seems unlikely that IgE 
antibodies play a direct role in the disease. The most recent findings about IgG4 antibodies 
to milk proteins add further evidence about the relevance of these proteins.
During the first years of the 21st century, many of the patients with alpha-gal syndrome 
presented to allergists and were consistently advised that their symptoms were not due to 
food allergy. This was because:
A. the onset of allergic reactions to meat in adult life was considered rare;
B. skin prick tests to meat showed 2- to 3-mm wheals at best (intradermal skin test 
results were positive); and
C. the patients reported long delays after eating red meat before the symptoms 
started.
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Without a specific assay for IgE antibodies to alpha-gal, it would have been very difficult to 
connect the dots.78 Equally, establishing that the IgE binding to meat extracts was IgE 
specific for an oligosaccharide provided a further enigma until it became clear that 
sensitization was occurring through the skin.
Today it is clear that the skin is an important route for IgE responses, that a large proportion 
of allergic disease involves conditions in which the relationship of exposure to disease is not 
obvious, and that the ability to measure IgE and IgG4 antibody levels to specific proteins can 
provide an important part of the diagnosis and management (Table III).
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FIG 1. 
Allergens become airborne and are inhaled in the form of particles, which range from 5 to 
30 μm in diameter (Table I). The number of allergen molecules free in the air is essentially 
zero, and none of the source materials are inhaled.
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FIG 2. 
Contrast between natural exposure to airborne allergen (A) and bronchial provocation with 
nebulized extract (B). Natural exposure is to relatively large particles, which contain a wide 
range of allergens and adjuvants.
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FIG 3. 
IgE antibodies in patients with EoE compared with those with 2 anaphylaxis syndromes: 
peanut and alpha-gal. Although IgE to milk, wheat, egg, and soy are common in children 
with EoE, the titers are generally low or very low.
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FIG 4. 
Contrast between 3 body surfaces that are relevant to the induction and maintenance of 
immune responses for food allergens: skin (keratinized squamous epithelium), esophagus 
(nonkeratinized squamous epithelium), and columnar epithelium in the intestines. We 
recognize that the lymphoid tissues draining the upper airways and mouth are also important 
for response to food allergens.
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TABLE II
Clinical and immunologic differences among 3 common forms of allergic disease
Peanut-induced anaphylaxis EoE
Delayed anaphylaxis to 
mammalian meat (alpha-gal 
syndrome)
Relevant allergens Ara h 1, Ara h 2 (peanut) Bos d 4, Bos d 5 (cow’s milk)
Wheat proteins
Alpha-gal*
Route of sensitization Skin Esophagus (?)
Skin unlikely
Skin
(Tick bites)
Risk factors Eczema Unknown Outdoor activity
Lipitor (?)
Serum IgE antibody High-titer IgE to peanut proteins (5–500 
IU/mL)
Low-titer or negative IgE to 
cow’s milk proteins† (<0.1–2 
IU/mL)
High-titer IgE to alpha-gal 
(often 10% to 30% of total 
IgE)
Treatment Diet free of peanut Oral immunotherapy Diet free of cow’s milk with 
swallowed cromolyn 4 times 
daily‡
Diet free of mammalian 
products
Prevention Prevent eczema
Feed peanut from 3 mo
Not known Avoid tick bites
Timing of reaction to 
foods
15–60 min to local and generalized swelling§ 12–24 h 3–6 h after eating red meat
*Chung et al28 and Commins et al.29
†
Erwin et al.47
‡
Erwin et al.79
§
Du Toit et al.48
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TABLE III
Relevance of specific IgE antibodies to the treatment of allergic disease
Disease IgE assay and skin test Role of IgE Treatment* Immunotherapyz
Hay fever Seasonal allergens Primary Avoidance† SCIT
Asthma Indoor and outdoor allergens Central
 A. Avoidance† SCIT
 B. Omalizumab†
Late onset and severe asthma AERD Not clear
Vocal chord Not relevant Voice therapy, etc† —
Indoor allergens Central
 A. Avoidance† SCIT
 B. Omalizumab†
Fungal Mixed Anti-fungal ?
Food allergy Immediate reactions Peanut, etc Primary Avoidance OIT
EoE Cow’s milk, wheat… Probably none Avoidance† SCIT?
Alpha-gal Syndrome Alpha-gal, beef… Primary Avoidance† —
*Antihistamines and local steroids, for example, are asked for all these diseases.
†
Dependent on identifying specific allergen or allergens.
‡OIT, Oral immunotherapy; SCIT, subcutaneous immunotherapy.
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